Inactive Instrument

Other languages China Biotech Services Holdings Limited Hong Kong S.E.

Equities

8037

BMG7713H1575

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

China Biotech Services Holdings Limited Announces Not Recommends Final Dividend for the Year Ended 31 December 2023	03-28
China Biotech Services Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-28
China Biotech Services Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	02-28
Pengbo Medical Technology Co., Ltd. Announces the Approval by the Hainan Provincial Medical Products Administration for the Import of Medical Devices	01-30
China Biotech Services Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13
China Biotech Services Holdings Limited Provides Group Earnings Guidance for the Nine Months Ended September 30, 2023	31/10/23
China Biotech Services Holdings Limited Announces Strategic Cooperation Framework Agreement with Astrazeneca Investment Co., Ltd	18/10/23
China Biotech Services Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/08/23
China Biotech Services Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023	01/08/23
China Biotech Services Holdings Limited Announces Redesignation of Chui Hoi Yam from an Executive Director to Non-Executive Director	30/06/23
China Biotech Services Holdings Limited Declares Final Dividend for the Year Ended 31 December 2022	16/05/23
China Biotech Services Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23
China Biotech Services Holdings Limited and The Chinese University of Hong Kong Enter into Memorandum of Understanding	02/05/23
China Biotech Services Holdings Limited Provides Group Earnings Guidance for the Three Months Ended 31 March 2023	28/04/23
China Biotech Services Holdings Limited Proposes Final Ordinary Dividend for the Year Ended December 31, 2022, Payable on 15 June 2023	24/03/23
China Biotech Services Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2022	28/02/23
China Biotech Services Holdings Limited Announces Board Changes	05/12/22
China Biotech Services Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
China Biotech Services Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Nine Months Ended 30 September 2022	04/11/22
China Biotech Services Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/08/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages China Biotech Services Holdings Limited Hong Kong S.E.

Equities

8037

BMG7713H1575

Other languages

Filters